Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
addiction, heroin
anticoagulant, complications of
bacterial endocarditis, neurologic manifestations of
basilar artery occlusion
CAT scan
CAT scan, abnormal
CAT scan, stereotactic localization
cerebral infarction, hemorrhagic
cerebrovascular accident
cerebrovascular accident, recurrent
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, young adult
cocaine
complications
controversies in neurology
diplopia
drug abuse
drug abuse, neurologic complications of
endocarditis
endocarditis, infectious
epidemiology of neurology
fibrinolytic agents
fibrinolytic agents, repeated use
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, exclusion criteria
fibrinolytic agents, intra-arterial local infusion
hypertension
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, incidence of
intracerebral hemorrhage, recurrent
intracerebral hemorrhage, treatment of
intravenous drug abuse
level of consciousness, decreased
mortality
neoplasm, metastatic to CNS
neoplasm, metastatic to CNS, hemorrhagic
neoplasm, metastatic to CNS-hemorrhage into
neoplasm, primary of CNS
neoplasm, primary of CNS-hemorrhage in
opiate
prognosis
review article
risk factors
safety
stereotaxic surgery
tissue plasminogen activator, intravenous
treatment of neurologic disorder
Showing articles 1100 to 1150 of 3820 << Previous Next >>

Trends of Tuberculosis Case Detection, Mortality and Co-Infection with HIV in Ghana: A Retrospective Cohort Study
PLOSONE 15:e0234878, Osel, E.,et al, 2020

Neurotoxic Manifestations of High-Dose Intrathecal Gadolinium Administration for CT Myelogram
Radiol Case Reports 15:1992-1995, Malalur, P. & Rajacic, P.C., 2020

Recent Administration of Iodinated Contrast Renders Core Infarct Estimation Inaccurate Using RAPID Software
AJNR 41:2235-2242, Copelan, A.Z.,et al, 2020

Neurological Impairments in a Patient Returning from Cuba
JAMA Neurol 77:1570-1571, Serlin, Y.,et al, 2020

Involuntary Groaning Induced by Levodopa Therapy in a Patient With Progressive Supranuclear Palsy
JAMA Neurol 77:1569, Park, J.E., 2020

Clinicopathologic conference, Cryptococcal meningoencephalitis and advanced HIV infection
NEJM 383:2572-2580, Case 40-2020, 2020

One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020

Initial Highly Effective Therapy for MS
Neurol 95:1114-1116, Wallin, M.T., 2020

Clinicopathologic Conference, HIV Type 2 Infection & Cerebral Toxoplasmosis
NEJM 383:859-866, Case 27-2020, 2020

Second Drug Okayed for Rare Central Nervous System Disease
JAMA 324:224, Jaklevic, M.C., 2020

Burning Pain in the Legs
NEJM 383:e18, Sacks, C.A., 2020

Contrast-Induced Encephalopathy After Endovascular Thrombectomy for Acute Ischemic Stroke
Stroke 51:3756-3759, Chu, Y.I.,et al, 2020

A 73-Year-Old Man with Recurrent Aphasia, Headaches, and Confusion
Neurol 95:e2595-e2599, Bose, G.,et al, 2020

Migraine
NEJM 383:1866-1876, Ashina, M., 2020

A Patient with a History of Weight Loss Presenting with Seizures
Neurol 95:e2038-e2042, Tang, G. & Benavides, D.R., 2020

Clinicopathologic Conference, Borrelia Miyamotoi Infection
NEJM 383:1578-1586, Case 32-2020, 2020

Case of Topical Metronidazole-Induced Encephalopathy
JAMA Neurol 77:1318-1319, Mathew, R.P. & Kunhimohammed, S.P., 2020

Progressive Multifocal Leukoencephalopathy in a Patient with Primary Amyloid Light-Chain Amyloidosis
Clin Neurol Neurosurg 192:doi105709, Katsuse, K.,et al, 2020

Mobile Stroke Unit Computed Tomography Angiography Substantially Shortens Door-to-Puncture Time
Stroke 51:1613-1615, Czap, A.L.,et al, 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Association of Innovations in Radiotherapy and Systemic Treatments with Clinical Outcomes in Patients with Melanoma Brain Metastasis From 2007 to 2016
JAMA doi:10.1001/JAMANETWORKOPEN.2020.8204, Brastianos, H.C.,et al, 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

MR Target Sign in Cerebral Aspergillosis
Neurohospitalist doi:10.1177/1941874420929191, Finelli, P.F., 2020

Contrast-Induced Encephalopathy Following Coronary Angiography
Neurol 94:e2491-e2494, Harada, Y.,et al, 2020

Relapse of Severe Neurosarcoidosis with Switch from Originator Infliximab to Biosimilar
Neurol 94:991-993, Kidd, D.P.,et al, 2020

Delayed Nonischemic Cerebral Enhancing Lesions Post Endovascular Coil Embolization
Neurol 94:e2402-e2403, Bettin, M.V. & Southerland, A.M., 2020

A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
NEJM 382:9-19,81, Amarenco, P.,et al, 2020

Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurol 77:184-191, Luna, G.,et al, 2020

Prevalence of Cannabis Withdrawal Symptoms Among People with Regular or Dependent Use of Cannabinoids
JAMA doi:10.1001/JAMANETWORKOPEN.2020.2370, Bahji, A.,et al, 2020

Clinicopathologic Conference, AA Amyloidosis, Complicated by Cerebral Mucormycosis
NEJM 382:1457-1466, Case 11-2020, 2020

Management and Outcome of Primary CNS Lymphoma in the Modern Era
Neurol 94:e1027-e1039, Houillier, C., et al, 2020

Myasthenia Gravis Following Dabrafenib and Trametinib for Metastatic Melanoma
Neurol 94:322-323, Zaloum, A.,et al, 2020

Chemotherapy-Associated Hyperammonemic Encephalopathy
Neurol 94:e874-e877, Briard, J.N.,et al, 2020

GQ1b-Seronegative Miller Fisher Syndrome Associated with Pembrolizumab
J Neuro-Ophthal 39:394-396, Green, K.E.,et al, 2019

Dupuytren, Ledderhose, and Peyronie Diseases after Primidone Use for Essential Tremor
Neurologist 24:150-151, Felipe, L.,et al, 2019

Medical Use of Cannabis in 2019
JAMA 322:974-975, Hill, K.P., 2019

Neurolymphomatosis
Neurol 93:e1229-e1230, DeBoer, S.R.,et al, 2019

Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019

Long-Term Safety and Efficacy of Eculizumab in Generalized Myasthenia Gravis
Muscle Nerve 60:14-24, Muppidi, S.,et al, 2019

Vaccine-Preventable Infections and Immunization in Multiple Sclerosis
Neurol 93:584-594, Farez, M.F.,et al, 2019

Reversible Cerebral Vasoconstriciton Syndrome
www.UptoDate.com, June, Singhal, A., 2019

Clinicopathologic Conference, Adenovirus Meningoencephalitis
NEJM 381:1459-1470, Case 31-2019, 2019

Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
NEJM 381:614-625, Pittock, S.J.,et al, 2019

Cytotoxic Lesions of the Corpus Callosum Caused by Thermogenic Dietary Supplements
AJNR 40:1304-1308, Galnares-Olalde, J.A.,et al, 2019

Pes Cavus and Neuropathy
Neurol 93:e823-e826, Alderson,J.,& Ghosh,P.S., 2019

Trial of Galcanezumab in Prevention of Episodic Cluster Headache
NEJM 381:132-141, Goadsby, P.J.,et al, 2019

Inebilizumab for the Treatment of Neuromyelitis Optica Spectrum Disorder (N-MOmentum): A Double-Blind, Randomised Placebo-Controlled Phase 2/3 Trial
Lancet 394:1352-1363,1304, Cree, B.A.C.,et al, 2019

Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019

Clinical Characteristics and Outcomes of Methamphetamine-Associated Intracerebral Hemorrhage
Neurol 93:e1-e7, Swor, D.E.,et al, 2019



Showing articles 1100 to 1150 of 3820 << Previous Next >>